Tong Ren Tang Technologies Co ( (HK:1666) ) has shared an announcement.
Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has entered into a strategic cooperation agreement with China Duty Free International Limited. This agreement aims to leverage both parties’ strengths to expand Tong Ren Tang’s overseas markets, focusing on innovative business models and exclusive product versions. The collaboration will enhance the company’s market positioning by integrating resources and exploring multi-dimensional cooperation in business, products, and culture, particularly in the Chinese health food and beverage sector.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in China, operating in the traditional Chinese medicine industry. The company, along with its subsidiaries, focuses on producing and distributing Chinese medicinal products, with a market focus on expanding its presence in overseas markets, particularly in countries along the ‘Belt and Road’ and Southeast Asia regions.
YTD Price Performance: -13.08%
Average Trading Volume: 800
Technical Sentiment Signal: Strong Buy
Current Market Cap: $802.7M
For an in-depth examination of 1666 stock, go to TipRanks’ Stock Analysis page.